“Development And Toxicological Evolution Of Pegylated Chitosan Nanoparticle For The Simultaneous Delivery Of Silymarin And Dehydroemetine For The Enhance Hepatic Targeting”. (2022) 2023. Journal of Pharmaceutical Negative Results, February, 4732-39. https://doi.org/10.47750/pnr.2022.13.S08.617.